- Home
- JQC vs TECX Comparison
JQC vs TECX Comparison
Compare JQC & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JQC
- TECX
- Stock Information
- Founded
- JQC 2003
- TECX 2019
- Country
- JQC United States
- TECX United States
- Employees
- JQC N/A
- TECX N/A
- Industry
- JQC Finance Companies
- TECX
- Sector
- JQC Finance
- TECX
- Exchange
- JQC Nasdaq
- TECX Nasdaq
- Market Cap
- JQC 800.1M
- TECX 647.7M
- IPO Year
- JQC N/A
- TECX 2018
- Fundamental
- Price
- JQC $5.75
- TECX $47.44
- Analyst Decision
- JQC
- TECX Strong Buy
- Analyst Count
- JQC 0
- TECX 5
- Target Price
- JQC N/A
- TECX $72.25
- AVG Volume (30 Days)
- JQC 714.6K
- TECX 93.8K
- Earning Date
- JQC 01-01-0001
- TECX 11-07-2024
- Dividend Yield
- JQC 11.13%
- TECX N/A
- EPS Growth
- JQC N/A
- TECX N/A
- EPS
- JQC N/A
- TECX N/A
- Revenue
- JQC N/A
- TECX N/A
- Revenue This Year
- JQC N/A
- TECX N/A
- Revenue Next Year
- JQC N/A
- TECX N/A
- P/E Ratio
- JQC N/A
- TECX N/A
- Revenue Growth
- JQC N/A
- TECX N/A
- 52 Week Low
- JQC $4.82
- TECX $1.40
- 52 Week High
- JQC $5.65
- TECX $53.34
- Technical
- Relative Strength Index (RSI)
- JQC 42.43
- TECX 53.77
- Support Level
- JQC $5.82
- TECX $42.83
- Resistance Level
- JQC $5.82
- TECX $48.85
- Average True Range (ATR)
- JQC 0.06
- TECX 3.42
- MACD
- JQC -0.02
- TECX -0.84
- Stochastic Oscillator
- JQC 30.36
- TECX 43.97
About JQC Nuveen Credit Strategies Income Fund Shares of Beneficial Interest
Nuveen Credit Strategies Income Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. The fund meets its investment objectives by investing its managed assets in senior secured and second lien loans, and its managed assets across the capital structure of companies (including equity securities) with a primary emphasis on high yield bonds, convertible securities and other forms of income-producing securities.
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.